MEC Plus

MEDPRO™ Talk - A Patient’s Perspective
MEDPRO™ Talk - A Patient’s Perspective
Shannon Baxter, PhD
Drug Brown and White Bagging - What is It and Where Does it Lead Us?
Drug Brown and White Bagging - What is It and Where Does it Lead Us?
Jorge Garcia, PharmD, MS, MHA, MBA, FACHE
Biosimilars as Front-Line Options for Cancer Care
Biosimilars as Front-Line Options for Cancer Care
Jorge Garcia, PharmD, MS, MHA, MBA, FACHE
Novel Therapeutic Strategies in Acute Myeloid Leukemia: Our Cup Runneth Over
Novel Therapeutic Strategies in Acute Myeloid Leukemia: Our Cup Runneth Over
Martin S Tallman - MD
Moving the Needle on Bladder Cancer Survival: A Urologist's Perspective
Moving the Needle on Bladder Cancer Survival: A Urologist's Perspective
Marc Dall'Era - MD
Current State of Lung Cancer Screening
Current State of Lung Cancer Screening
David Tom Cooke - MD - FACS
Advances in Oncology 2019: Breast Cancer Update
Advances in Oncology 2019: Breast Cancer Update
Mili Arora - MD
Translating Clinical Trials' Results into Clinical Practice
Translating Clinical Trials' Results into Clinical Practice
Panel
Optimal Therapies in Genitourinary Cancers
Optimal Therapies in Genitourinary Cancers
Panel
Optimal Therapeutic Strategies in GI Cancers
Optimal Therapeutic Strategies in GI Cancers
Panel
Challenging Cases in Breast Cancer
Challenging Cases in Breast Cancer
Panel
T-Cell Lymphomas: New Therapeutic Approaches
T-Cell Lymphomas: New Therapeutic Approaches
Jasmine Zain - MD
Management of Immune-Related Adverse Events
Management of Immune-Related Adverse Events
Christine Teklehaimanote - MSN - GNP-BC - AOCNP
Sequencing Drugs in mCRPC
Sequencing Drugs in mCRPC
Sandy Srinivas - MD
Updates in Targeted Therapy for NSCLC
Updates in Targeted Therapy for NSCLC
Jonathan Riess - MD - MS
State of the Art: Hormone-Sensitive Prostate Cancer
State of the Art: Hormone-Sensitive Prostate Cancer
David I Quinn - MBBS - PhD - FRACP - FACP
Neural Stem Cell-Based Anti-Cancer Gene Therapy for Gliomas
Neural Stem Cell-Based Anti-Cancer Gene Therapy for Gliomas
Jana Portnow - MD
DLBCL: The Latest and Greatest
DLBCL: The Latest and Greatest
Leslie L Popplewell - MD - FACP
HER2+ Breast Cancer: State of the Art
HER2+ Breast Cancer: State of the Art
Mark Pegram - MD
How I Treat Metastatic Urothelial Cancer after IO Therapy Fails
How I Treat Metastatic Urothelial Cancer after IO Therapy Fails
Mamta Parikh - MD - MS
Urothelial Cancer: New Strategies
Urothelial Cancer: New Strategies
Chong-xian Pan - MD - PhD - MS
Immunotherapy for Advanced Non-Small Cell Lung Cancer
Immunotherapy for Advanced Non-Small Cell Lung Cancer
Sukhmani K Padda
Advances in Immunotherapy
Advances in Immunotherapy
Arta M Monjazeb - MD - PhD
Acute Lymphoblastic Leukemia: Latest Advances
Acute Lymphoblastic Leukemia: Latest Advances
Gabriel N Mannis - MD
Colorectal Cancer: State of the Science
Colorectal Cancer: State of the Science
Heinz-Josef Lenz
New Immunotherapeutic Strategies: Checkpoint Inhibitors and Beyond
New Immunotherapeutic Strategies: Checkpoint Inhibitors and Beyond
Peter P Lee - MD
Targeted Therapies in Metastatic RCC: Monotherapy Versus Combination Therapy
Targeted Therapies in Metastatic RCC: Monotherapy Versus Combination Therapy
Primo N Lara - Jr. - MD
Innovative Early Phase Clinical Trial Designs
Innovative Early Phase Clinical Trial Designs
Shivaani Kummar - MD - FACP
Pancreatic Cancer: Emerging Strategies
Pancreatic Cancer: Emerging Strategies
Edward J Kim - MD - PhD